+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Contract Research Organization (CRO) Market 2022-2026

  • ID: 5578818
  • Report
  • April 2022
  • Region: Global
  • 120 Pages
  • TechNavio
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Azelix LLC
  • Eurofins Scientific SE
  • GENETICIST Inc.
  • ICON plc
  • Linical Co. Ltd.
  • PSI CRO AG
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the contract research organization (CRO) market and it is poised to grow by $40.00 bn during 2022-2026, accelerating at a CAGR of 10.06% during the forecast period. The report on the contract research organization (CRO) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growth of the biopharmaceutical industry, an increase in research and development expenditure globally will spur industry statistics of CROs, and regulation of clinical trials to propel the growth of contract research organizations.

The contract research organization (cro) market analysis includes end-user segment and geographic landscape.

The contract research organization (cro) market is segmented as below:

By End-user

  • Pharmaceutical and biopharmaceutical companies
  • Medical device companies
  • Academic institutes

By Geography

  • North America
  • Europe
  • APAC
  • Rest of World (ROW)

This study identifies the growing demand for cros as one of the prime reasons driving the contract research organization (cro) market growth during the next few years. Also, increasing number of clinical trials and growing trend of outsourcing and cost savings enabled by using cro services will lead to sizable demand in the market.

The report on contract research organization (cro) market covers the following areas:

  • Contract research organization (cro) market sizing
  • Contract research organization (cro) market forecast
  • Contract research organization (cro) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract research organization (cro) market vendors that include Azelix LLC, BioAgile Therapeutics Pvt. Ltd, Charles River Laboratories International Inc., Clinical Trial Service BV, Eurofins Scientific SE, Firma Clinical Research LLC, Frontage Holdings Corp., GENETICIST Inc., Guires Ltd., ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Linical Co. Ltd., Medpace Holdings Inc., PAREXEL International Corp., Pharmaron Beijing Co. Ltd., PSI CRO AG, Syneos Health Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd.. Also, the contract research organization (cro) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Azelix LLC
  • Eurofins Scientific SE
  • GENETICIST Inc.
  • ICON plc
  • Linical Co. Ltd.
  • PSI CRO AG

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by End-user
5.1 Market segments
Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
5.2 Comparison by End-user
Exhibit 26: Chart on Comparison by End-user
Exhibit 27: Data Table on Comparison by End-user
5.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026
Exhibit 28: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
5.4 Medical device companies - Market size and forecast 2021-2026
Exhibit 32: Chart on Medical device companies - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Medical device companies - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Medical device companies - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Medical device companies - Year-over-year growth 2021-2026 (%)
5.5 Academic institutes - Market size and forecast 2021-2026
Exhibit 36: Chart on Academic institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Academic institutes - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Academic institutes - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Academic institutes - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by End-user
Exhibit 40: Market opportunity by End-user ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share by geography 2021-2026 (%)
Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 APAC - Market size and forecast 2021-2026
Exhibit 54: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on APAC - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 China - Market size and forecast 2021-2026
Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity by geography
Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Charles River Laboratories International Inc.
Exhibit 89: Charles River Laboratories International Inc. - Overview
Exhibit 90: Charles River Laboratories International Inc. - Business segments
Exhibit 91: Charles River Laboratories International Inc. - Key news
Exhibit 92: Charles River Laboratories International Inc. - Key offerings
Exhibit 93: Charles River Laboratories International Inc. - Segment focus
10.4 Eurofins Scientific SE
Exhibit 94: Eurofins Scientific SE - Overview
Exhibit 95: Eurofins Scientific SE - Business segments
Exhibit 96: Eurofins Scientific SE - Key news
Exhibit 97: Eurofins Scientific SE - Key offerings
Exhibit 98: Eurofins Scientific SE - Segment focus
10.5 ICON plc
Exhibit 99: ICON plc - Overview
Exhibit 100: ICON plc - Product / Service
Exhibit 101: ICON plc - Key offerings
10.6 IQVIA Holdings Inc.
Exhibit 102: IQVIA Holdings Inc. - Overview
Exhibit 103: IQVIA Holdings Inc. - Business segments
Exhibit 104: IQVIA Holdings Inc. - Key news
Exhibit 105: IQVIA Holdings Inc. - Key offerings
Exhibit 106: IQVIA Holdings Inc. - Segment focus
10.7 Laboratory Corp. of America Holdings
Exhibit 107: Laboratory Corp. of America Holdings - Overview
Exhibit 108: Laboratory Corp. of America Holdings - Business segments
Exhibit 109: Laboratory Corp. of America Holdings - Key news
Exhibit 110: Laboratory Corp. of America Holdings - Key offerings
Exhibit 111: Laboratory Corp. of America Holdings - Segment focus
10.8 Medpace Holdings Inc.
Exhibit 112: Medpace Holdings Inc. - Overview
Exhibit 113: Medpace Holdings Inc. - Product / Service
Exhibit 114: Medpace Holdings Inc. - Key offerings
10.9 PAREXEL International Corp.
Exhibit 115: PAREXEL International Corp. - Overview
Exhibit 116: PAREXEL International Corp. - Product / Service
Exhibit 117: PAREXEL International Corp. - Key offerings
10.10 Syneos Health Inc.
Exhibit 118: Syneos Health Inc. - Overview
Exhibit 119: Syneos Health Inc. - Business segments
Exhibit 120: Syneos Health Inc. - Key offerings
Exhibit 121: Syneos Health Inc. - Segment focus
10.11 Thermo Fisher Scientific Inc.
Exhibit 122: Thermo Fisher Scientific Inc. - Overview
Exhibit 123: Thermo Fisher Scientific Inc. - Business segments
Exhibit 124: Thermo Fisher Scientific Inc. - Key news
Exhibit 125: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 126: Thermo Fisher Scientific Inc. - Segment focus
10.12 WuXi AppTec Co. Ltd.
Exhibit 127: WuXi AppTec Co. Ltd. - Overview
Exhibit 128: WuXi AppTec Co. Ltd. - Business segments
Exhibit 129: WuXi AppTec Co. Ltd. - Key offerings
Exhibit 130: WuXi AppTec Co. Ltd. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 131: Inclusions checklist
Exhibit 132: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 133: Currency conversion rates for US$
11.4 Research methodology
Exhibit 134: Research methodology
Exhibit 135: Validation techniques employed for market sizing
Exhibit 136: Information sources
11.5 List of abbreviations
Exhibit 137: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on End-user - Market share 2021-2026 (%)
Exhibits 25: Data Table on End-user - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by End-user
Exhibits 27: Data Table on Comparison by End-user
Exhibits 28: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Medical device companies - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Medical device companies - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Medical device companies - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Medical device companies - Year-over-year growth 2021-2026 (%)
Exhibits 36: Chart on Academic institutes - Market size and forecast 2021-2026 ($ million)
Exhibits 37: Data Table on Academic institutes - Market size and forecast 2021-2026 ($ million)
Exhibits 38: Chart on Academic institutes - Year-over-year growth 2021-2026 (%)
Exhibits 39: Data Table on Academic institutes - Year-over-year growth 2021-2026 (%)
Exhibits 40: Market opportunity by End-user ($ million)
Exhibits 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 42: Chart on Market share by geography 2021-2026 (%)
Exhibits 43: Data Table on Market share by geography 2021-2026 (%)
Exhibits 44: Chart on Geographic comparison
Exhibits 45: Data Table on Geographic comparison
Exhibits 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 82: Market opportunity by geography ($ million)
Exhibits 83: Impact of drivers and challenges in 2021 and 2026
Exhibits 84: Overview on Criticality of inputs and Factors of differentiation
Exhibits 85: Overview on factors of disruption
Exhibits 86: Impact of key risks on business
Exhibits 87: Vendors covered
Exhibits 88: Matrix on vendor position and classification
Exhibits 89: Charles River Laboratories International Inc. - Overview
Exhibits 90: Charles River Laboratories International Inc. - Business segments
Exhibits 91: Charles River Laboratories International Inc. - Key news
Exhibits 92: Charles River Laboratories International Inc. - Key offerings
Exhibits 93: Charles River Laboratories International Inc. - Segment focus
Exhibits 94: Eurofins Scientific SE - Overview
Exhibits 95: Eurofins Scientific SE - Business segments
Exhibits 96: Eurofins Scientific SE - Key news
Exhibits 97: Eurofins Scientific SE - Key offerings
Exhibits 98: Eurofins Scientific SE - Segment focus
Exhibits 99: ICON plc - Overview
Exhibits 100: ICON plc - Product / Service
Exhibits 101: ICON plc - Key offerings
Exhibits 102: IQVIA Holdings Inc. - Overview
Exhibits 103: IQVIA Holdings Inc. - Business segments
Exhibits 104: IQVIA Holdings Inc. - Key news
Exhibits 105: IQVIA Holdings Inc. - Key offerings
Exhibits 106: IQVIA Holdings Inc. - Segment focus
Exhibits 107: Laboratory Corp. of America Holdings - Overview
Exhibits 108: Laboratory Corp. of America Holdings - Business segments
Exhibits 109: Laboratory Corp. of America Holdings - Key news
Exhibits 110: Laboratory Corp. of America Holdings - Key offerings
Exhibits 111: Laboratory Corp. of America Holdings - Segment focus
Exhibits 112: Medpace Holdings Inc. - Overview
Exhibits 113: Medpace Holdings Inc. - Product / Service
Exhibits 114: Medpace Holdings Inc. - Key offerings
Exhibits 115: PAREXEL International Corp. - Overview
Exhibits 116: PAREXEL International Corp. - Product / Service
Exhibits 117: PAREXEL International Corp. - Key offerings
Exhibits 118: Syneos Health Inc. - Overview
Exhibits 119: Syneos Health Inc. - Business segments
Exhibits 120: Syneos Health Inc. - Key offerings
Exhibits 121: Syneos Health Inc. - Segment focus
Exhibits 122: Thermo Fisher Scientific Inc. - Overview
Exhibits 123: Thermo Fisher Scientific Inc. - Business segments
Exhibits 124: Thermo Fisher Scientific Inc. - Key news
Exhibits 125: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 126: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 127: WuXi AppTec Co. Ltd. - Overview
Exhibits 128: WuXi AppTec Co. Ltd. - Business segments
Exhibits 129: WuXi AppTec Co. Ltd. - Key offerings
Exhibits 130: WuXi AppTec Co. Ltd. - Segment focus
Exhibits 131: Inclusions checklist
Exhibits 132: Exclusions checklist
Exhibits 133: Currency conversion rates for US$
Exhibits 134: Research methodology
Exhibits 135: Validation techniques employed for market sizing
Exhibits 136: Information sources
Exhibits 137: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Azelix LLC
  • Eurofins Scientific SE
  • GENETICIST Inc.
  • ICON plc
  • Linical Co. Ltd.
  • PSI CRO AG
The publisher recognizes the following companies as the key players in the global contract research organization (CRO) market: Azelix LLC, BioAgile Therapeutics Pvt. Ltd, Charles River Laboratories International Inc., Clinical Trial Service BV, Eurofins Scientific SE, Firma Clinical Research LLC, Frontage Holdings Corp., GENETICIST Inc., Guires Ltd., ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Linical Co. Ltd., Medpace Holdings Inc., PAREXEL International Corp., Pharmaron Beijing Co. Ltd., PSI CRO AG, Syneos Health Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing demand for CROs.`

According to the report, one of the major drivers for this market is the growth of biopharmaceutical industry.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Azelix LLC
  • BioAgile Therapeutics Pvt. Ltd
  • Charles River Laboratories International Inc.
  • Clinical Trial Service BV
  • Eurofins Scientific SE
  • Firma Clinical Research LLC
  • Frontage Holdings Corp.
  • GENETICIST Inc.
  • Guires Ltd.
  • ICON plc
  • IQVIA Holdings Inc.
  • Laboratory Corp. of America Holdings
  • Linical Co. Ltd.
  • Medpace Holdings Inc.
  • PAREXEL International Corp.
  • Pharmaron Beijing Co. Ltd.
  • PSI CRO AG
  • Syneos Health Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co. Ltd.
Note: Product cover images may vary from those shown